27820098JClinPediatrVol.27No.8Aug.2009,、,、。,:(No.05012)::zhoumin7266@126.comIL-1β、IL-6、TNF-α1121131.(610017);2.(400014);3.··:IL-1β、IL-6、TNF-α。,ELISAIL-1β、IL-6、TNF-α,、、AnnexinV,。HE、。IL-1βTNF-α(P<0.05),IL-6。、AnnexinV。,IL-1β,IL-1β、TNF-α,AnnexinVTNF-α。,IVIG,IL-1βTNF-α。。IL-1β、TNF-α,。,,。[,2009,27(8):753-757]:;;;:Q95-3:A:1000-3606(2009)08-0753-05ThechangeofcytokinesanditsrelationshipwithplateletsinimmunevasculitisLIXiao-hui1,ZHOUMin1,XUYou-hua2,XUMing1,LIJin-shu1,YANGMo3(1.DepartmentofHematology,ChengduChildren'sHospital,Chengdu610017,Sichuan,China;2.Departmentofhematology,Children'sHospitalAffiliatedtoChongqingMedicalUniversity,Chongqing400014,China;3.DepartmentofChildhoodandAdolesenceSciences,LiKaShingFacuityofMedicine,TheUniversityofHongkong,Hongkong,China)Abstract:ObjectivesTostudythechangesofcytokines,plateletsandtheirrelationshipinimmunevasculitis.MethodsTherabbitmodelsofimmunevasculitiswereestablishedbytwiceintravenousinjectionofbovineserumalbumin.Peripheralplateletnumber,plateletaggregationandAnnexinVweredetected.ThelevelsofserumInterleukin-1β(IL-1β)、Interleukin-6(IL-6)、tumornecrosisfactor-α(TNF-α)weredetectedbyenzyme-linkedimmunosorbentassay.Thepathologicalchangesofimmunevasculitiswereanalyzedbyhematoxylinandeosinstaining,elasticfibersstainingandelectronmicroscopy.ResultsThelevelsofIL-1β,TNF-α,plateletnumber,plateletaggregationandAnnexinVinthevasculitisgroupweresignificantlyhigherthanthoseinthecontrolgroup(P<0.05),whilethelevelofIL-6wasnotsignificantlydifferentfromthatinthecontrolgroup.TheserumlevelofIL-1βwascorrelatedwithplateletnumber,whilebothserumIL-1βandTNF-αlevelscorrelatedwiththeplateletaggregation.TNF-αlevelalsocorrelatedwithAnnexinV.AspirintreatmentcouldinhibittheserumlevelsofIL-1βandTNF-α,plateletnumberandactivity.IVIGcouldinhibitthelevelsofIL-1βandTNF-αbutcouldnotinhibitthenumberandactivityofplatelet.Bothdrugscouldimprovethevesseldamagefromimmunevasculitis.ConclusionsCytokinesIL-1β,TNF-αandplateletmightbeinvolvedinthepathogenesisofimmunevasculitis,andaspirincoulddecreasetheinflammationdamageofvesselsinimmunevasculitisthroughinhibitingcytokinesandplatelets.(JClinPediatr,2009,27(8):753-757)Keywords:vasculitis;cytokines;platelet;aspirin753··27820098JClinPediatrVol.27No.8Aug.2009,,,[1],[2]。,,。,。11.1(),3~4,<800g,,。。。(IVIG)。FITCAnnexinV。IL-1β、IL-6、TNF-αELISA。1.2[3,4],10%2.5ml/kg,2.5ml/kg。2,,,。1.34,12。①(normal);②(control);③(aspirin):100mg/(kg·d)[30~50mg/(kg·d)],7d10mg/(kg·d),qd[3~5mg/(kg·d)],;④IVIG:2g/kg,iv,d1。IVIG24,,。1.427()28(),2ml,37℃,1h,2000r/min,10min(12cm),,-80℃,。ELISAIL-1β、IL-6、TNF-α,。1.57()28()。1.5.120μl,(SysmexKX-21,)。1~3h。1.5.22ml,3.8%,1∶9。800r/min×10min(8cm),(plateletrichplasma,PRP),3000r/min×15min(8cm),(plateletpoorplasma,PPP)。(100~600)×109/L。Born,TYXN-96。ADP2μmol/L,、,(maximumaggregationrate,MAR),10mm/min,5min。2h。1.5.3-AnnexinV2ml,。PBS2,1×,1×106/ml。100μl,5μlFITC-AnnexinV,15min,1×400μl,(FACSCalibur,BectonDickinson)。(FSC)(SSC)、,1×105。CELLQuest。2h。1.6728,,,;10%,-,。[4,5],1。1.7±(x±s),SPSS12.0,Kruskal-Wallis,Spearman,P<0.05。754··27820098JClinPediatrVol.27No.8Aug.20093:1),P<0.05;2),P<0.05;3)aspirin,P<0.05:1),P<0.05;2),P<0.052(x±s,pg/ml)22.1IL-1βTNF-α,(P<0.05)。IVIG,,。,IVIG,,。IL-6,(P>0.05)。。2。2.2,;,,(P=0.007)。IVIG。,4,。3。,IL-1β(r=0.55,P=0.012),TNF-α(r=0.402,P=0.07)。2.3,(P=0.043)。,,(P=0.012),IVIG。4,。3。,IL-1βTNF-α(r=0.603、0.433,P<0.05)。2.4,AnnexinV(22.55±6.00)%,(6.31±1.84)%,(P=0.000)。,AnnexinV[(13.95±5.29)%],(P=0.009)。IVIGAnnexinV,(18.33±6.08)%,,(P=0.168)。281(x±s)755··27820098JClinPediatrVol.27No.8Aug.200911),P<0.05,AnnexinV。,AnnexinVIL-1β(r=0.469,P=0.148),TNF-α(r=0.823,P=0.001)。2.5,、、、;,,,。、,,。,。,。IVIG,,3.17±0.75、1.92±0.66、1.75±0.51,(χ2=16.397,P<0.05),。,IVIG,。1。3,,,[3,4],。、,。(KD),。KD[6]。,、、,、。,、。,、,[3,4]。,。、、。IL-1β、IL-6、TNF-α,。IL-1β、、,,,[7]。IL-6,C(CRP),,,KD、、Wegener's,[8]。TNF-α,,、、,-1、E-、ICAM-1,、[9]。,IL-1βTNF-α(P<0.05),。IL-6,,,。、,、。,,、、(vWF),、,A2、IL-1β,。,,CD62PTNF-α,[10]。,,。,IL-1β,IL-1β、TNF-α,AnnexinVTNF-α。756··27820098JClinPediatrVol.27No.8Aug.2009。、,IL-1βTNF-α,、。,,T,IL-1β、TNF-α,[11]。IVIG、,IL-1βTNF-α。IVIG,IVIG。,,。,,,,,。,,。,,。:[1]LeviM,vanderPollT,BüllerHR.Bidirectionalrelationbetweeninflammationandcoagulation[J].Circulation,2004,109(22):2698-2704.[2]FreedmanJE.Molecularregulationofplatelet-dependentthrombosis[J].Circulation,2005,112(17):2725-2734.[3]OnouchiZ,IkutaK,NagamatsuK,etal.Coronaryarteryaneurysmsdevelopinweanlingrabbitswithserumsicknessbutnotinmaturerabbits.AnexperimentalmodelforKawasakidiseaseinhumans[J].Angiology,1995,46(8):679-687.[4],,,.[J].,2003,41(3):227-228.[5]NeilDA,LynchSV,HardieIR,etal.Coldstoragepreservationandwarmischaemicinjurytoisolatedarterialsegments:endothelialcellinjury[J].AmJTransplant,2002,2(5):400-409.[6],.(2005)[J].,2007,25(1):76-80.[7],,.IL-1β[J].,2006,12(6):265-267.[8]LinCY,YangYH,LeeCC,etal.Thrombopoietinandinterleukin-6levelsinHenoch-Sch觟nleinpurpura[J].JMicrobiolImmunolInfect,2006,39(6):476-482.[9]Hui-YuenJS,DuongTT,YeungRS.TNF-alphaisnecessaryforinductionofcoronaryarteryinflammationandaneurysmformationinananimalmodelofKawasakidisease[J].JImmunol,2006,176(10):6294